Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2025-12-25 @ 10:34 PM
Study NCT ID:
NCT01164267
Status:
COMPLETED
Last Update Posted:
2013-11-25
First Post:
2010-07-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)
Sponsor:
International Extranodal Lymphoma Study Group (IELSG)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2010-07-15
First Submit QC Date:
None
Study First Post Date:
2010-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-11-21
Last Update Post Date:
2013-11-25
Last Update Post Date Type:
ESTIMATED